NOCIL Limited

25%

ues Sales Volume* (MT) Revenue from Operation (Rs. In crores) Operating EBITDA (Rs. In crores) +25% 144 +25% 275 56 115 230 222 107 100* 53 +19% 37 31 7 Q1FY20 Q1FY21 Q2FY21 Q3FY21

19%

crores) Operating EBITDA (Rs. In crores) +25% 144 +25% 275 56 115 230 222 107 100* 53 +19% 37 31 7 Q1FY20 Q1FY21 Q2FY21 Q3FY21 Q1FY20 Q1FY21 Q2FY21 Q3FY21 Q1FY20 Q1FY21 Q2FY21

10%

In crores) Q4 9M Q4 9M 1,011 846 212 634 FY19 FY20 FY21 FY19 FY20 FY21 will register 8-10% growth, inspite of weak Q1FY21 due to COVID-19 603 FY21 5 CHINA + 1 STRATEGY Rubber Chemicals

43.4%

ion % Employee Expenses Other Operating Expenses Operating EBITDA 275 155 119 194 93 102 43.4% 52.3% 18 65 37 19 47 36 Y-o-Y 41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222

52.3%

Employee Expenses Other Operating Expenses Operating EBITDA 275 155 119 194 93 102 43.4% 52.3% 18 65 37 19 47 36 Y-o-Y 41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222 115 10

41%

enses Operating EBITDA 275 155 119 194 93 102 43.4% 52.3% 18 65 37 19 47 36 Y-o-Y 41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222 115 107 48.1% 17 58 31 25% 12% 18%

17%

Operating EBITDA 275 155 119 194 93 102 43.4% 52.3% 18 65 37 19 47 36 Y-o-Y 41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222 115 107 48.1% 17 58 31 25% 12% 18% 603

3%

erating EBITDA 275 155 119 194 93 102 43.4% 52.3% 18 65 37 19 47 36 Y-o-Y 41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222 115 107 48.1% 17 58 31 25% 12% 18% 603 325

48.1%

8 65 37 19 47 36 Y-o-Y 41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222 115 107 48.1% 17 58 31 25% 12% 18% 603 325 278 634 282 352 46.1% 55.6% 51 151 76 57 155 140

12%

-o-Y 41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222 115 107 48.1% 17 58 31 25% 12% 18% 603 325 278 634 282 352 46.1% 55.6% 51 151 76 57 155 140 Performance is not co

18%

41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222 115 107 48.1% 17 58 31 25% 12% 18% 603 325 278 634 282 352 46.1% 55.6% 51 151 76 57 155 140 Performance is not compara

46.1%

21 9MFY20 Remarks 222 115 107 48.1% 17 58 31 25% 12% 18% 603 325 278 634 282 352 46.1% 55.6% 51 151 76 57 155 140 Performance is not comparable with same period last year as

Liquidity position

1

Investor Relations Advisors

1

Liquidity position

• Company has comfortable liquidity position Mask & Sanitization distribution & compulsion • Compulsion for the use of mask and hand sanitization every 2 hours and following all the protocols and guidelines • Company is debt free and are taking care of its working capital requirements through internal accruals 7 Standalone Profit & Loss Statement Rs. In Crores Q3 FY21 Q3 FY20 Net Revenue from Operations Raw Material Value Addition * Value Addition % Employee Expenses Other Operating Expenses Operating EBITDA 275 155 119 194 93 102 43.4% 52.3% 18 65 37 19 47 36 Y-o-Y 41% 17% 3% Q2 FY21 Q-o-Q 9MFY21 9MFY20 Remarks 222 115 107 48.1% 17 58 31 25% 12% 18% 603 325 278 634 282 352 46.1% 55.6% 51 151 76 57 155 140 Performance is not comparable with same period last year as Q1FY21 performance was impacted due to lockdown Operating EBITDA Margin 13.4% 18.4% 14.1% 12.5% 22.1% Depreciation Interest Other Income Profit Before Tax Tax Net Profit 9 0 2 29 7 22 8 0 1 29 8 21 9 0 1 23 6 17 0% 7% 26 1 1

Investor Relations Advisors

NOCIL Ltd. CIN: L99999MH1961PLC012003 Strategic Growth Advisors Pvt. Ltd. CIN: U74140MH2010PTC204285 Mr. P. Srinivasan - CFO finance@nocil.com Ms. Mugdha Khare mugdha.khare@nocil.com Mr. Jigar Kavaiya Jigar.kavaiya@sgapl.net +91 9920602034 www.nocil.com www.sgapl.net 26